Seed Grants in Regenerative Medicine: New “Georgia Partners” Program

Call for “Georgia Partners” Seed Grants in Regenerative Medicine

Deadline: November 1, 2013

University of Georgia, Emory University and Georgia Institute of Technology in partnership with the Regenerative Engineering and Medicine Center announce a new “Georgia Partners” seed grant program.

This funding mechanism is intended to stimulate new, collaborative research in regenerative medicine between UGA and Emory or UGA and Georgia Tech.  The team of investigators must have a minimum of two investigators and must have an equal partnership of faculty from UGA / Emory or UGA / Georgia Tech and resources split between the universities as equally as possible.

Georgia Partnership Research Grants – This funding mechanism may support collaborative projects at earlier stages of development in the “high risk, high yield” category or projects with a high potential for translation.  Budgets for these proposals may not exceed $70,000.  A total of four seed grants are expected to be awarded.

Deadline:  The deadline for submission of proposals is November 1, 2013.  Funding will begin November 15, 2013.

General Guidelines Applicable to both Funding Mechanisms

ELIGIBILITY

·       All faculty members with primary appointments at Emory, UGA or Georgia Tech are eligible to apply.

·       Proposals from those addressing new questions or taking new approaches are encouraged.

ADDITIONAL DETAILS

·       Applications are for funding through June 30, 2014.

·       Funds may be used for Ph.D. student/postdoc support, animal studies, supplies, and limited travel as related to the conduct of the research.  Faculty salary support is not appropriate.  For Georgia Tech students supported on these funds, their tuition will be waived.

·       Applicants are reminded that these are seed grants that are intended to promote the acquisition of extramural funding.

·       The success of the research grant program will be measured by the publications and follow-on extramural funding from the seed grant and generation of intellectual property, and/or the initiation of clinical studies.  Publications arising from a Emory / UGA Partnership grant funded should include the following citation in any publication, press release, or other document resulting from direct or indirect ACTSI support, “Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR00454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

·       The Regenerative Engineering and Medicine Center should be recognized in any grant or publication acknowledgements.

·       Recipient must comply with the NIH public access policy and should sign the NOA acknowledging so.

·       The application must include a description of the long term funding strategy

·       Failure to submit in a timely progress report will result in the exclusion from further award opportunities from this seed mechanism.

RENEWALS

·       Prior recipients of seed grants funding must fill out a progress report of work completed under the prior funding.  This will be collected on an on-line system and should include a summary of the work, publications and presentations and funding applied for and/or received.  If extramural grant applications were unsuccessful, reviews and scores from those applications should be included.

GENERAL FORMAT

·       The format for these grants is the same as used by the NIH for standard R01 applications with the exception that there is a 3 page limit to the application (excluding budget and abstract).

Applications should include the proposal, a detailed budget using NIH forms and NIH format biosketches for the investigators (see specific instructions section below). http://grants.nih.gov/grants/peer/guidelines_general/budget_information.pdf

 

DETAILED FORMATTING INSTRUCTION

•  Application should include*:

1. Cover page with the following information:

i.        Type of research application *(T1 – T4)

ii.       Title of Project

iii.      Applicant Name(s), Titles, Email Addresses

iv.      Department, Institution

v.       Requested Award Amount (Direct Costs)

2. Application must include an Abstract.

3. Biosketches of all key personnel (must include eRA Commons Username)

4. All applications must include the NIH PHS 398 Budget Form with justification. (Funds may be used for data collection and analysis, research lab supplies, and student/postdoc/technical support that are directly related to the conduct of the research.  Salary support for university faculty, hospital medical/nursing staff, or administrative support is not appropriate.)

5. All Federal and university rules and regulations regarding the administration of   grants apply to these funds.  Costs subject to CAS approval, such as computers, general purpose equipment, office supplies and the like, may not be charged to this award.

6. Application must provide a statement on Human Subjects Protection, as outlined in the PHS 398 instructions (if applicable).

7. Applicant must provide the following items before funding is released (if relevant):

a.         IRB approval letter

b.         Approved protocol

b.          IACUC approval

c.          Any additional relevant certifications (CITI, etc.)

8. If Human Embryonic Stem Cells are being used, the applicant must include the registration number of the cell lines.

REVIEW

·       Scoring will be based on standard NIH criteria with an emphasis on translational potential for strategic priority grants and innovation for the innovative research grants. http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-025.html

SUBMISSION & QUESTIONS

Technical questions regarding the program may be addressed to Meg McDevitt mcdevitt@ibb.gatech.edu. The proposal should be submitted to the  REM website as a word document – all one document except for NIH Biosketches, which can be uploaded separately.